Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Plasma Exchange and Immunoadsorption in Pediatric Inflammatory Optic Neuropathy Resistant to Corticosteroid Therapy: Four French Cases.
Prescriptive Oriented Drug Analysis of Multiple Sclerosis Disease by LC-UV in Whole Human Blood.
2'-Hydroxy ceramide in membrane homeostasis and cell signaling.
Autoimmune disease in people with multiple sclerosis and their relatives: a systematic review and meta-analysis.
Intestinal Interleukin-17 Receptor Signaling Mediates Reciprocal Control of the Gut Microbiota and Autoimmune Inflammation.
An update on the use of natalizumab in the treatment of multiple sclerosis: appropriate patient selection and special considerations.
Cardiovascular effects of fingolimod: Relevance, detection and approach.
[Efficacy and safety of natalizumab in multiple sclerosis: data from the first five years of TOP (Tysabri Observational Program) study].
Mosaic Subventricular Origins of Forebrain Oligodendrogenesis.
An MRI-defined measure of cerebral lesion severity to assess therapeutic effects in multiple sclerosis.
MxA mRNA expression as a biomarker of interferon beta response in multiple sclerosis patients.
[Anti-myelin oligodendrocyte glycoprotein (MOG) antibody].
Neurologic Disorders in Immunocompetent Patients with Autochthonous Acute Hepatitis E.
Alarmin' Immunologists: IL-33 as a Putative Target for Modulating T Cell-Dependent Responses.
[Treatment of multiple sclerosis: new approaches to treat case by case].
Therapeutic Cleavage of Anti-Aquaporin-4 Autoantibody in Neuromyelitis Optica by an Igg-Selective Proteinase.
Kappa opioid receptor activation alleviates experimental autoimmune encephalomyelitis and promotes oligodendrocyte-mediated remyelination.
Synaptic plasticity in multiple sclerosis and in experimental autoimmune encephalomyelitis.
The magnetic resonance imaging 'rule of five': predicting the occurrence of relapse.
The development of hematopoietic and mesenchymal stem cell transplantation as an effective treatment for multiple sclerosis.
Activation of microglial P2Y12 receptor is required for outward potassium currents in response to neuronal injury.
Interleukin 12 (IL-12) family cytokines: Role in immune pathogenesis and treatment of CNS autoimmune disease.
Correction: Treatment with Vitamin D/MOG Association Suppresses Experimental Autoimmune Encephalomyelitis.
Modulation of the Left Prefrontal Cortex with High Frequency Repetitive Transcranial Magnetic Stimulation Facilitates Gait in Multiple Sclerosis.
Epidemiological, clinical and immunological aspects of neuromyelitis optica (NMO).

Pages